Fraxiparine 2850IU Injection belongs to the class of ‘anticoagulants’ (blood thinners), primarily used to prevent and treat harmful blood clots. Fraxiparine 2850IU Injection is also used to prevent stroke or heart attack and deep vein thrombosis (blood clots in leg veins). It reduces the risk of blood clots in patients undergoing larger orthopaedic surgeries like elective hip surgeries. A blood clot can occur in any part of the body, leading to a heart attack, stroke and damage to organs (even coma or death). Blood clots can reach the arteries or veins in the organs like the brain, kidney, heart, lungs and limbs.

Fraxiparine 2850IU Injection contains ‘Nadroparin’ that belongs to the class of low molecular weight heparins (LMWHs). It works by inhibiting the production of clotting factors. This further prevents the conversion of fibrinogen (soluble protein) to fibrin (insoluble protein), thereby preventing blood clot formation. Fraxiparine 2850IU Injection helps in the free flow of blood through your veins, making it less likely to form a serious blood clot. 

Fraxiparine 2850IU Injection will be administered by a healthcare professional, do not self-administer. Your doctor will advise the dosage and duration of Fraxiparine 2850IU Injection based on your medical condition. The common side effects of Fraxiparine 2850IU Injection include easy bruising, injection site pain and swelling, mild irritation, weakness, numbness, dizziness, headache, and confusion. Most of these side effects of Fraxiparine 2850IU Injection do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor. 

Do not stop taking Fraxiparine 2850IU Injection abruptly since it may worsen your condition and increase the risk of a future heart attack. Let your doctor know if you are allergic to Fraxiparine 2850IU Injection or have kidney/liver diseases and active bleeding issues (like peptic ulcer, brain haemorrhage). Fraxiparine 2850IU Injection is not recommended for use during pregnancy and breastfeeding; however, please seek medical advice. The patient should inform the doctor that they are taking Fraxiparine 2850IU Injection before any surgery is scheduled or any new medicine is taken. Please stay away from activities that may increase your risk of bleeding, like contact sports and using sharp objects like razors and nail cutters.

Fraxiparine 2850IU Injection is composed of Nadroparin, an anticoagulant or a blood thinner. It is low molecular weight heparin and prevents the formation of blood clots by inhibiting the production of clotting factors. It also reduces the risk of blood clots in patients undergoing larger orthopaedic surgeries like elective hip surgeries. Fraxiparine 2850IU Injection helps in the free flow of blood, thereby preventing the risk of heart attack, stroke, deep vein thrombosis (blood clot in the vein), and pulmonary embolism (blood clots in the arteries of lungs). Fraxiparine 2850IU Injection is used to prevent blood clotting in extracorporeal circulation (apparatus carrying the blood outside the body) during haemodialysis (purifying blood in a person whose kidney are abnormally functioning) and hemofiltration (renal replacement therapy) processes.

Before taking Fraxiparine 2850IU Injection, let your doctor know if you have a history of liver and kidney diseases or allergic reactions to Fraxiparine 2850IU Injection. Inform your doctor beforehand if you have a risk of internal bleeding (stomach ulcer), blood disorders (bleeding inside any tissues, organs or joints of your body), a recent injury/surgery or a planned surgery (including dental) in the next few days, a clot in an artery of your brain (ischaemic stroke), eye problems like diabetic retinopathy, spinal problems, artificial heart valves, and high blood pressure. Fraxiparine 2850IU Injection is not recommended for use during pregnancy and breastfeeding; however, please seek medical advice. Try avoiding alcohol to prevent any side effects’ occurrence further. If you experience dizziness, do not drive or operate machinery. Fraxiparine 2850IU Injection is not recommended in people younger than 18 years of age. Store Fraxiparine 2850IU Injection at temperatures not exceeding 25°C.